Леналидомид-Тева - analogs
Components: Lenalidomide |
|||||||||
Pharmgroups: Other antitumor agents |
|||||||||
| Prices in pharmacies: — Instructions Леналидомид-Тева | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Enalapril ✘ (incl) Potassium aspartate and magnesium aspartate ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
| ≈100% | Revlimid neutral | 1328€ |
| ≈100% | Lenalidomide neutral | — |
| ≈100% | Lenalidomide-KRKA neutral | — |
| ≈100% | Lenalidomide-TL neutral | — |
| ≈100% | Lenalidomide Canon neutral | — |
| ≈100% | Lenalidomide-nativ neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 23% — Фаридак neutral [Panobinostat]
- 19% 91.7€ Boramilan neutral [Bortezomib]
- 18% — Бортезомиб-промомед neutral [Bortezomib]
- 18% 2417.8€ Ninlaro neutral [Ixazomib]
- 18% — Bortezomib neutral [Bortezomib]
- 18% — Иксазомиба цитрат neutral [Ixazomib]
- 18% 35-453.9€ BoramilanFS neutral [Bortezomib]
- 18% — Бортезомиб (форма-II) neutral [Bortezomib]
- 18% — Бортезомиб-Тева neutral [Bortezomib]
- 16% 788.9€ Kyprolis neutral [Carfilzomib]
- 16% 1381.2€ Empliciti Dangerous 🔍 [Elotuzumab]
- 14% — Бортезомиб Канон neutral [Bortezomib]
- 14% 104.5€ Велмиб3.5 neutral [Bortezomib]
- 14% — Майборте neutral [Bortezomib]
- 14% — Милатиб neutral [Bortezomib]
- 13% — Verozomib neutral [Bortezomib]
- 13% — Bortezol neutral [Bortezomib]
- 13% 992.7€ Talcenna neutral [Talazoparib]
- 13% 140-149.4€ Velcade neutral [Bortezomib]
- 13% 136.3€ Бартизар neutral [Bortezomib]
- 13% — БОРАТЕРИН neutral [Bortezomib]
- 13% 8.2-13.2€ Anastrozole Dangerous 🔍 [Anastrozole]
- 13% — Брасер Dangerous 🔍 [Anastrozole]
- 13% — Anastreks Dangerous 🔍 [Anastrozole]
- 13% 4€ Axastrol Dangerous 🔍 [Anastrozole]
- 13% — Сарклиза Dangerous 🔍 [Isatuximab]
- 13% — Anastrozole Sun Dangerous 🔍 [Anastrozole]
- 13% — Estarizol Dangerous 🔍 [Anastrozole]
- 13% 194.3-777.1€ Darzalex Dangerous 🔍 [Daratumumab]
- 12% 6352.5-6726.4€ Imnovid Dangerous 🔍 [Pomalidomide]
- 12% 73.4€ Venclexta neutral [Venetoclax]
- 12% — Иматанго Dangerous 🔍 [Pomalidomide]
- 12% — Pomalidomide-TL Dangerous 🔍 [Pomalidomide]
- 11% 2964.5€ Пикрэй neutral [Alpelisib]
- 11% 9.6-10.9€ Аназалес Dangerous 🔍 [Anastrozole]
- 11% — Бендамустина гидрохлорид моногидрат Dangerous 🔍 [Bendamustine]
- 11% — Ковада Dangerous 🔍 [Bendamustine]
- 11% 15-21€ Цервикон -ДИМ neutral [Diindolylmethane]
- 11% 11-11.6€ Anastrozole-Kabi Dangerous 🔍 [Anastrozole]
- 11% — ГРАСТИГЕН Dangerous 🔍 [Bendamustine]
- 11% — Бендамустин Канон Dangerous 🔍 [Bendamustine]
- 11% — Бендамустин-промомед Dangerous 🔍 [Bendamustine]
- 11% — РОЗУСТИН Dangerous 🔍 [Bendamustine]
- 11% — Меркудиес Dangerous 🔍 [Bendamustine]
- 10% — Factor tumor necrosis-thymosine alpha-1 recombinant neutral [Tumor necrosis factor-thymosine alpha-1 recombinant]
- 10% — Oncofage Negative 🔍 [Proteine]
- 10% 607-629.6€ Lisomustine neutral
- 10% — Икатибант neutral [Icatibant]
- 10% — Kisqali neutral [Ribociklib]
- 10% — Ftordesoxyglucose, 18 F neutral [Fludeoxyglucose [18F]]
Learn more about the selection of analogues
- The drug has «Леналидомид-Тева» 15 full analogs, the cheapest - Revlimid (1328€); 51 analog by action, the most similar - Boramilan (91.7€).
- Medical online service has selected the best substitutes for Леналидомид-Тева based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Леналидомид-Тева analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.